STOCK TITAN

TMO affiliate files Form 144 to sell 7,250 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Thermo Fisher Scientific (TMO): Form 144 notice of proposed sale. A holder filed to sell 7,250 shares of common stock, showing an aggregate market value of $4,104,237.84. The approximate sale date is 10/27/2025, with the shares listed on the NYSE. The filing lists 377,612,121 shares outstanding. The broker named is Fidelity Brokerage Services LLC.

The shares to be sold were acquired on 10/27/2025 via an option originally granted on 02/26/2019, with payment stated as cash. The notice also reports recent sales by Marc N. Casper, including 10,000 shares on 08/06/2025 for $4,518,207.00 and 17,104 shares on 10/24/2025 for $9,809,820.07.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 disclosing a planned affiliate sale.

Form 144 is a notice of a proposed sale of restricted or control securities under Rule 144. This filing lists a plan to sell 7,250 shares of Thermo Fisher Scientific common stock, with an aggregate market value of $4,104,237.84 and an approximate sale date of 10/27/2025. The broker is Fidelity Brokerage Services LLC and the shares trade on the NYSE.

The filing also details how the shares were acquired: via an option granted on 02/26/2019, acquired on 10/27/2025, with cash payment. It lists prior three‑month sales by Marc N. Casper, providing dates, share amounts, and gross proceeds. These disclosures satisfy Rule 144’s transparency requirements.

Impact on the company is typically limited because proceeds go to the selling holder. Actual sale activity depends on market conditions and holder decisions.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Thermo Fisher Scientific (TMO) disclose in this Form 144?

A notice of intent to sell 7,250 shares of common stock with an aggregate market value of $4,104,237.84, with an approximate sale date of 10/27/2025.

How were the TMO shares to be sold acquired?

They were acquired on 10/27/2025 via an option granted on 02/26/2019, with payment listed as cash.

Which broker and exchange are listed for the proposed TMO sale?

The broker is Fidelity Brokerage Services LLC, and the shares are listed on the NYSE.

How many Thermo Fisher (TMO) shares are listed as outstanding?

The filing lists 377,612,121 shares outstanding.

What recent sales by Marc N. Casper are reported?

Examples include 10,000 shares on 08/06/2025 for $4,518,207.00 and 17,104 shares on 10/24/2025 for $9,809,820.07.

What is the aggregate market value of the proposed 7,250-share sale?

The filing reports an aggregate market value of $4,104,237.84.

Does the Form 144 indicate who receives sale proceeds?

Form 144 concerns sales by the holder; amounts listed for prior sales are reported as gross proceeds.
Thermo Fishr Sci

NYSE:TMO

TMO Rankings

TMO Latest News

TMO Latest SEC Filings

TMO Stock Data

232.46B
375.10M
0.16%
91.87%
1.04%
Diagnostics & Research
Measuring & Controlling Devices, Nec
Link
United States
WALTHAM